Translation of remote ischaemic preconditioning into clinical practice.
Reduction of the burden of ischaemia-reperfusion injury is the aim of most treatments for cardiovascular and cerebrovascular disease. Although many strategies have proven benefit in the experimental arena, few have translated to clinical practice. Scientific and practical reasons might explain this...
主要な著者: | Kharbanda, R, Nielsen, T, Redington, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2009
|
類似資料
-
BETA-CATENIN PATHWAY EXPRESSION IN HUMAN MYOCARDIUM IS INCREASED BY A REMOTE ISCHAEMIC PRECONDITIONING STIMULUS
著者:: Contractor, H, 等
出版事項: (2009) -
Increased Beta-Catenin Pathway Expression by a Remote Ischaemic Preconditioning Stimulus: First Evidence in Humans
著者:: Contractor, H, 等
出版事項: (2009) -
ADENOSINE RECEPTOR INHIBITION ABOLISHES REMOTE ISCHAEMIC PRECONDITIONING IN HUMANS
著者:: Contractor, H, 等
出版事項: (2009) -
Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study.
著者:: Kharbanda, R, 等
出版事項: (2006) -
Remote ischaemic preconditioning (rIPC) reduces cardiac and pulmonary dysfunction following experimental cardiopulmonary bypass
著者:: Kharbanda, R, 等
出版事項: (2004)